Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

miR-21 is overexpressed in NPM1-mutant acute myeloid leukemias.

Riccioni R, Lulli V, Castelli G, Biffoni M, Tiberio R, Pelosi E, Lo-Coco F, Testa U.

Leuk Res. 2015 Feb;39(2):221-8. doi: 10.1016/j.leukres.2014.11.001. Epub 2014 Nov 18.

PMID:
25543261
2.

MicroRNA-146a and AMD3100, two ways to control CXCR4 expression in acute myeloid leukemias.

Spinello I, Quaranta MT, Riccioni R, Riti V, Pasquini L, Boe A, Pelosi E, Vitale A, Foà R, Testa U, Labbaye C.

Blood Cancer J. 2011 Jun;1(6):e26. doi: 10.1038/bcj.2011.24. Epub 2011 Jun 24.

3.

Immunophenotypic features of acute myeloid leukaemia patients exhibiting high FLT3 expression not associated with mutations.

Riccioni R, Pelosi E, Riti V, Castelli G, Lo-Coco F, Testa U.

Br J Haematol. 2011 Apr;153(1):33-42. doi: 10.1111/j.1365-2141.2011.08577.x. Epub 2011 Feb 20.

PMID:
21332708
4.

Hemopoietic and angiogenetic progenitors in healthy athletes: different responses to endurance and maximal exercise.

Bonsignore MR, Morici G, Riccioni R, Huertas A, Petrucci E, Veca M, Mariani G, Bonanno A, Chimenti L, Gioia M, Palange P, Testa U.

J Appl Physiol (1985). 2010 Jul;109(1):60-7. doi: 10.1152/japplphysiol.01344.2009. Epub 2010 May 6.

5.

The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor.

Riccioni R, Dupuis ML, Bernabei M, Petrucci E, Pasquini L, Mariani G, Cianfriglia M, Testa U.

Blood Cells Mol Dis. 2010 Jun 15;45(1):86-92. doi: 10.1016/j.bcmd.2010.03.008. Epub 2010 May 4.

PMID:
20444629
6.

Transcriptional silencing of the ETS1 oncogene contributes to human granulocytic differentiation.

Lulli V, Romania P, Riccioni R, Boe A, Lo-Coco F, Testa U, Marziali G.

Haematologica. 2010 Oct;95(10):1633-41. doi: 10.3324/haematol.2010.023267. Epub 2010 Apr 30.

7.

Correlations between progression of coronary artery disease and circulating endothelial progenitor cells.

Briguori C, Testa U, Riccioni R, Colombo A, Petrucci E, Condorelli G, Mariani G, D'Andrea D, De Micco F, Rivera NV, Puca AA, Peschle C, Condorelli G.

FASEB J. 2010 Jun;24(6):1981-8. doi: 10.1096/fj.09-138198. Epub 2010 Jan 7.

PMID:
20056714
8.

Bone marrow-derived progenitors are greatly reduced in patients with severe COPD and low-BMI.

Huertas A, Testa U, Riccioni R, Petrucci E, Riti V, Savi D, Serra P, Bonsignore MR, Palange P.

Respir Physiol Neurobiol. 2010 Jan 31;170(1):23-31. doi: 10.1016/j.resp.2009.10.003. Epub 2009 Nov 4.

PMID:
19895908
9.

A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes.

Careccia S, Mainardi S, Pelosi A, Gurtner A, Diverio D, Riccioni R, Testa U, Pelosi E, Piaggio G, Sacchi A, Lavorgna S, Lo-Coco F, Blandino G, Levrero M, Rizzo MG.

Oncogene. 2009 Nov 12;28(45):4034-40. doi: 10.1038/onc.2009.255. Epub 2009 Sep 14.

PMID:
19749800
10.

Colocalization of the VEGF-R2 and the common IL-3/GM-CSF receptor beta chain to lipid rafts leads to enhanced p38 activation.

Saulle E, Riccioni R, Coppola S, Parolini I, Diverio D, Riti V, Mariani G, Laufer S, Sargiacomo M, Testa U.

Br J Haematol. 2009 May;145(3):399-411. doi: 10.1111/j.1365-2141.2009.07627.x. Epub 2009 Feb 24.

PMID:
19245429
11.

Interleukin (IL)-3/granulocyte macrophage-colony stimulating factor/IL-5 receptor alpha and beta chains are preferentially expressed in acute myeloid leukaemias with mutated FMS-related tyrosine kinase 3 receptor.

Riccioni R, Diverio D, Riti V, Buffolino S, Mariani G, Boe A, Cedrone M, Ottone T, Foà R, Testa U.

Br J Haematol. 2009 Feb;144(3):376-87. doi: 10.1111/j.1365-2141.2008.07491.x. Epub 2008 Nov 13.

PMID:
19036083
12.

Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways.

Lunghi P, Giuliani N, Mazzera L, Lombardi G, Ricca M, Corradi A, Cantoni AM, Salvatore L, Riccioni R, Costanzo A, Testa U, Levrero M, Rizzoli V, Bonati A.

Blood. 2008 Sep 15;112(6):2450-62. doi: 10.1182/blood-2007-10-114348. Epub 2008 Jun 26.

13.

Resistance of acute myeloid leukemic cells to the triterpenoid CDDO-Imidazolide is associated with low caspase-8 and FADD levels.

Riccioni R, Senese M, Diverio D, Riti V, Mariani G, Boe A, LoCoco F, Foà R, Peschle C, Sporn M, Testa U.

Leuk Res. 2008 Aug;32(8):1244-58. doi: 10.1016/j.leukres.2007.12.008. Epub 2008 Mar 4.

PMID:
18304628
14.

Hairy Cell Leukemia.

Riccioni R, Galimberti S, Petrini M.

Curr Treat Options Oncol. 2007 Apr;8(2):129-34. Review.

PMID:
17926010
15.

M4 and M5 acute myeloid leukaemias display a high sensitivity to Bortezomib-mediated apoptosis.

Riccioni R, Senese M, Diverio D, Riti V, Buffolino S, Mariani G, Boe A, Cedrone M, Lo-Coco F, Foà R, Peschle C, Testa U.

Br J Haematol. 2007 Oct;139(2):194-205.

PMID:
17897295
16.

deltaN-p73 is a transcriptional target of the PML/RARalpha oncogene in myeloid differentiation.

Mainardi S, Pelosi A, Palescandolo E, Riccioni R, Fontemaggi G, Diverio D, Testa U, Sacchi A, Grignani F, Lo-Coco F, Levrero M, Blandino G, Rizzo MG.

Cell Death Differ. 2007 Nov;14(11):1968-71. Epub 2007 Aug 10. No abstract available.

17.

Recombinant human granulocyte colony-stimulating factor administration in a case of neutropenia due to increased neutrophil sequestration.

Carulli G, Lazzeri E, Lagomarsini G, Zucca A, Cannizzo E, Riccioni R, Petrini M.

Clin Ter. 2007 May-Jun;158(3):235-7.

PMID:
17612284
18.

Expression of Tie-2 and other receptors for endothelial growth factors in acute myeloid leukemias is associated with monocytic features of leukemic blasts.

Riccioni R, Diverio D, Mariani G, Buffolino S, Riti V, Saulle E, Petrucci E, Cedrone M, Lo-Coco F, Foà R, Peschle C, Testa U.

Stem Cells. 2007 Aug;25(8):1862-71. Epub 2007 Apr 19.

19.

A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells.

Petrucci E, Pasquini L, Petronelli A, Saulle E, Mariani G, Riccioni R, Biffoni M, Ferretti G, Benedetti-Panici P, Cognetti F, Scambia G, Humphreys R, Peschle C, Testa U.

Gynecol Oncol. 2007 May;105(2):481-92. Epub 2007 Feb 9.

PMID:
17292950
20.

Deregulation of apoptosis in acute myeloid leukemia.

Testa U, Riccioni R.

Haematologica. 2007 Jan;92(1):81-94. Review.

21.

PEG-Filgrastim activity on granulocyte functions.

Fazzi R, Orciuolo E, Trombi L, Mattii L, Battola B, Riccioni R, Carulli G, Galimberti S, Petrini M.

Leuk Res. 2007 Oct;31(10):1453-5. Epub 2007 Jan 2. No abstract available.

PMID:
17197023
22.

Podocalyxin is expressed in normal and leukemic monocytes.

Riccioni R, Calzolari A, Biffoni M, Senese M, Riti V, Petrucci E, Pasquini L, Cedrone M, Lo-Coco F, Diverio D, Foà R, Peschle C, Testa U.

Blood Cells Mol Dis. 2006 Nov-Dec;37(3):218-25. Epub 2006 Oct 23.

PMID:
17059890
23.

Glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor differently modifies actin polymerization in neutrophils.

Zucca A, Brizzi S, Riccioni R, Azzarà A, Ghimenti M, Carulli G.

Clin Ter. 2006 Jan-Feb;157(1):19-24.

PMID:
16669548
24.

High efficacy of Rituximab in indolent HCV-related lymphoproliferative disorders associated with systemic autoimmune diseases.

Cervetti G, Mechelli S, Riccioni R, Galimberti S, Caracciolo F, Petrini M.

Clin Exp Rheumatol. 2005 Nov-Dec;23(6):877-80.

PMID:
16396708
25.

Primary lymphoma of the bladder: case report.

Riccioni R, Carulli G, de Maria M, Pacini S, Cagno C, Selli C, Petrini M.

Am J Hematol. 2006 Jan;81(1):77-8. No abstract available.

26.

In vitro dual effect of arsenic trioxide on hemopoiesis: inhibition of erythropoiesis and stimulation of megakaryocytic maturation.

Saulle E, Riccioni R, Pelosi E, Stafness M, Mariani G, De Tuglie G, Peschle C, Testa U.

Blood Cells Mol Dis. 2006 Jan-Feb;36(1):59-76. Epub 2005 Dec 15.

PMID:
16360329
27.

Fluoroquinolone resistance in hematopoietic stem cell transplant recipients with infectious complications.

Bonadio M, Morelli G, Mori S, Riccioni R, Papineschi F, Petrini M.

Biomed Pharmacother. 2005 Oct;59(9):511-6. Epub 2005 Sep 23.

PMID:
16274955
28.

Diphtheria toxin fused to variant human interleukin-3 induces cytotoxicity of blasts from patients with acute myeloid leukemia according to the level of interleukin-3 receptor expression.

Testa U, Riccioni R, Biffoni M, Diverio D, Lo-Coco F, Foà R, Peschle C, Frankel AE.

Blood. 2005 Oct 1;106(7):2527-9. Epub 2005 May 31.

29.

TRAIL decoy receptors mediate resistance of acute myeloid leukemia cells to TRAIL.

Riccioni R, Pasquini L, Mariani G, Saulle E, Rossini A, Diverio D, Pelosi E, Vitale A, Chierichini A, Cedrone M, Foà R, Lo Coco F, Peschle C, Testa U.

Haematologica. 2005 May;90(5):612-24.

30.

Immunophenotypic features of acute myeloid leukemias overexpressing the interleukin 3 receptor alpha chain.

Riccioni R, Rossini A, Calabrò L, Diverio D, Pasquini L, Lococo F, Peschle C, Testa U.

Leuk Lymphoma. 2004 Aug;45(8):1511-7.

PMID:
15370201
31.

A new complex rearrangement involving the ETV6, LOC115548, and MN1 genes in a case of acute myeloid leukemia.

Belloni E, Trubia M, Mancini M, Derme V, Nanni M, Lahortiga I, Riccioni R, Confalonieri S, Lo-Coco F, Di Fiore PP, Pelicci PG.

Genes Chromosomes Cancer. 2004 Nov;41(3):272-7.

PMID:
15334551
32.

Bilateral primary renal lymphoma treated by surgery and chemotherapy.

Cupisti A, Riccioni R, Carulli G, Paoletti S, Tognetti A, Meola M, Francesca F, Barsotti G, Petrini M.

Nephrol Dial Transplant. 2004 Jun;19(6):1629-33. Review. No abstract available.

PMID:
15150359
33.

Expansion of TcRalphabeta+CD3+CD4-CD8- (CD4/CD8 double-negative) T lymphocytes in a case of staphylococcal toxic shock syndrome.

Carulli G, Lagomarsini G, Azzarà A, Testi R, Riccioni R, Petrini M.

Acta Haematol. 2004;111(3):163-7.

PMID:
15034239
34.

Low dose 2-CdA schedule activity in splenic marginal zone lymphomas.

Riccioni R, Caracciolo F, Galimberti S, Cecconi N, Petrini M.

Hematol Oncol. 2003 Dec;21(4):163-8.

PMID:
14735554
35.

Interleukin-3 receptor in acute leukemia.

Testa U, Riccioni R, Diverio D, Rossini A, Lo Coco F, Peschle C.

Leukemia. 2004 Feb;18(2):219-26. Review.

PMID:
14671644
37.

C-fms expression correlates with monocytic differentiation in PML-RAR alpha+ acute promyelocytic leukemia.

Riccioni R, Saulle E, Militi S, Sposi NM, Gualtiero M, Mauro N, Mancini M, Diverio D, Lo Coco F, Peschle C, Testa U.

Leukemia. 2003 Jan;17(1):98-113.

PMID:
12529666
38.

Elevated expression of IL-3Ralpha in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis.

Testa U, Riccioni R, Militi S, Coccia E, Stellacci E, Samoggia P, Latagliata R, Mariani G, Rossini A, Battistini A, Lo-Coco F, Peschle C.

Blood. 2002 Oct 15;100(8):2980-8.

39.

Human acute stem cell leukemia with multilineage differentiation potential via cascade activation of growth factor receptors.

Testa U, Torelli GF, Riccioni R, Muta AO, Militi S, Annino L, Mariani G, Guarini A, Chiaretti S, Ritz J, Mandelli F, Peschle C, Foa R.

Blood. 2002 Jun 15;99(12):4634-7.

40.

Unusual morphology in a case of large granular cell leukemia.

Galimberti S, Riccioni R, Azzarà A, Testi R, Fazzi R, Testi C, Petrini M.

Ann Hematol. 2001 Dec;80(12):755-7. Epub 2001 Oct 13.

PMID:
11797119
41.

[Registry of genetic and malformative diseases in the province of Macerata].

Mercuri A, Amadori O, Andreozzi A, Antonelli S, Biritognolo A, Bizzarri V, Brocani P, Cardini E, Ciucciuvè P, Corneli A, Costantini S, Di Paolo R, Dolci M, Eugeni CE, Galvagno A, Gentilucci P, Giustozzi G, Gobbi C, Gradozzi U, Grelloni M, Medorini W, Murri B, Pasquali-Coluzzi F, Riccioni R, Rossi R, Ruggeri AG, Salvucci MC, Seri A, Scuppa U, Silvestri L, Sorelli L, Toscanelli A, Venanzetti N, Perri PF, Gabrielli O.

Acta Biomed Ateneo Parmense. 2000;71 Suppl 1:493-5. Italian.

PMID:
11424795
42.
43.
44.

Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis.

De Maria R, Testa U, Luchetti L, Zeuner A, Stassi G, Pelosi E, Riccioni R, Felli N, Samoggia P, Peschle C.

Blood. 1999 Feb 1;93(3):796-803.

45.

Secondary leukemia responsive to retinoic acid with abnormal localization of RARalpha protein: a report of two cases.

Leone G, Sica S, Ortu La Barbera E, Testa U, Riccioni R, Labbaye C, Peschle C, Zollino M.

Blood. 1998 Jun 15;91(12):4811-2. No abstract available.

46.

The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blasts.

Testa U, Grignani F, Samoggia P, Zanetti C, Riccioni R, Lo Coco F, Diverio D, Felli N, Passerini CG, Grell M, Pelicci PG, Peschle C.

J Clin Invest. 1998 May 15;101(10):2278-89.

47.

Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells.

Shao W, Fanelli M, Ferrara FF, Riccioni R, Rosenauer A, Davison K, Lamph WW, Waxman S, Pelicci PG, Lo Coco F, Avvisati G, Testa U, Peschle C, Gambacorti-Passerini C, Nervi C, Miller WH Jr.

J Natl Cancer Inst. 1998 Jan 21;90(2):124-33.

PMID:
9450572
48.

Improved rapid detection of the PML/RARalpha fusion gene in acute promyelocytic leukemia.

Diverio D, Riccioni R, Pistilli A, Buffolino S, Avvisati G, Mandelli F, Lo Coco F.

Leukemia. 1996 Jul;10(7):1214-6.

PMID:
8684004
49.

Analysis of the PML/RAR-α Fusion Gene in Acute Promyelocytic Leukemia by Reverse-Transcription Polymerase Chain Reaction : Technical Recommendations, Advantages, and Pitfalls.

Diverio D, Luciano A, Riccioni R, Coco FL, Biondi A.

Methods Mol Med. 1996;6:47-54. doi: 10.1385/0-89603-341-4:47.

PMID:
21380696
50.

Combined cytogenetic, FISH and molecular analysis in acute promyelocytic leukaemia at diagnosis and in complete remission.

Mancini M, Nanni M, Cedrone M, Diverio D, Avvisati G, Riccioni R, De Cuia MR, Fenu S, Alimena G.

Br J Haematol. 1995 Dec;91(4):878-84.

PMID:
8547133

Supplemental Content

Loading ...
Support Center